Home › Stocks › CCCC › All Fund Holders
CCCC — C4 THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 39 · Reported value held: $226.32M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Morgan Stanley history | Q2 2026 | 8.87M | $41.41M | 0.00% | Reduce |
| BlackRock Inc history | Q2 2026 | 7.90M | $36.88M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 4.75M | $20.65M | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 4.28M | $20.01M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 3.53M | $16.49M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 3.47M | $16.20M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 2.66M | $12.41M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 2.52M | $11.78M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 4.38M | $8.37M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 1.74M | $8.13M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 1.19M | $5.56M | 0.01% | Reduce |
| Northern Trust Corp history | Q2 2026 | 1.16M | $5.42M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 894.05K | $4.18M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 828.97K | $3.87M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 781.06K | $3.65M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 452.70K | $2.11M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 290.23K | $1.36M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 249.52K | $1.17M | 0.00% | New |
| Wellington Management Group history | Q2 2026 | 227.77K | $1.06M | 0.00% | New |
| Marshall Wace history | Q2 2026 | 227.00K | $1.06M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 215.39K | $1.01M | 0.00% | Reduce |
| Point72 Asset Management history | Q2 2026 | 173.97K | $812.42K | 0.00% | Add |
| AQR Capital Management history | Q2 2025 | 383.79K | $548.82K | 0.00% | Add |
| CPP Investments history | Q2 2026 | 101.50K | $474.00K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 98.87K | $461.74K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 49.39K | $230.65K | 0.00% | Add |
| Royce & Associates history | Q1 2024 | 23.60K | $192.84K | 0.00% | Reduce |
| Balyasny Asset Management history | Q4 2024 | 42.53K | $153.12K | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 31.23K | $145.87K | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 27.51K | $128.49K | 0.00% | New |
| Franklin Resources history | Q4 2024 | 34.24K | $123.27K | 0.00% | Hold |
| Principal Global Investors history | Q1 2024 | 13.24K | $108.15K | 0.00% | Reduce |
| Farallon Capital Management history | Q1 2026 | 28.00K | $73.64K | 0.00% | Hold |
| Legal & General Investment Management America history | Q2 2026 | 9.83K | $45.92K | 0.00% | New |
| Janus Henderson Group history | Q1 2023 | 11.08K | $34.74K | 0.00% | Reduce |
| PNC Financial Services history | Q1 2025 | 15.32K | $24.50K | 0.00% | Reduce |
| Amundi US history | Q1 2023 | 3.02K | $9.19K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 155.88K | $728 | 0.00% | Add |
| Lazard Asset Management history | Q4 2024 | 22.69K | $81 | 0.00% | New |